Remedi Supplies Additional Portable X-ray Devices for India's Tuberculosis Diagnosis and Elimination Program

Remedi has supplied an additional 750 units of its portable X-ray device, the REMEX-KA6, to India.

According to Remedi on July 9, the company was selected as the final supplier in the global tender for India's National Tuberculosis Elimination Program (NTEP), announced last year by the Central Medical Services Society (CMSS) under the Ministry of Health and Family Welfare of the Indian federal government. Following the supply of 1,534 units last year, Remedi delivered an additional 750 units in the first half of this year, achieving sales of approximately 4 billion won.

The Indian government is building a system that goes beyond hospital-centered diagnostics, by bringing diagnostics directly to sites such as rural and fishing communities where medical infrastructure is lacking. After a pilot rollout in 2024, the Indian government began expanding its portable X-ray equipment through global tenders starting in 2025.

Currently, Remedi's REMEX-KA6 units are deployed at more than 2,300 public healthcare institutions across India, serving as core equipment for the 'Mobile X-ray Tuberculosis Diagnosis and Treatment' initiative and have been in operation for an extended period. The company explained that the devices play a key role not only in infectious disease response but also in strengthening primary healthcare in rural and underserved areas.

Bongho Cho, CEO of Remedi, stated, "The Indian government expressed high satisfaction and purchased an additional 750 units," adding, "We plan to strengthen our local sales activities and initiate local assembly and production so that Remedi's portable X-ray devices can continue to be supplied in the large-scale government tenders scheduled over the next several years."

This content was produced with the assistance of AI translation services.